Parexel Publishes Findings on Making Clinical Research More Accessible for Gender-Diverse Populations

Parexel has published findings and recommendations for making clinical research more accessible and welcoming for transgender and nonbinary people.

While there are nearly 1.6 million transgender people in the US alone, of the thousands interventional clinical trial results published on PubMed from 2018 to 2022, Parexel notes less than one percent included participation of transgender and nonbinary patients. Many have deep-rooted reservations about healthcare and worry the risks of participating in a clinical trial would outweigh its benefits.

Through collaborating with partners and their patient advisory council and extensive research, Parexel identified five roadblocks to participation and eight solutions for designing more equitable clinical trials for transgender and nonbinary patients.

Download the study here.